Scott Andrew Smith - 14 Jun 2023 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Scott A. Smith
Issuer symbol
BCAB
Transactions as of
14 Jun 2023
Transactions value $
$0
Form type
4
Filing time
15 Jun 2023, 18:43:52 UTC
Previous filing
01 Jun 2023
Next filing
03 Jul 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (Right to Buy) Award $0 +50,000 $0 50,000 14 Jun 2023 Common Stock 50,000 $3.55 Direct F1
transaction BCAB Stock Option (Right to Buy) Award $0 +5,895 $0 5,895 14 Jun 2023 Common Stock 5,895 $3.55 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 14, 2024 or (b) the day before the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.
F2 Fully vested and exercisable.